PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34359939-0 2021 CK2alpha/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway. Doxorubicin 39-50 casein kinase 2 alpha 2 Homo sapiens 0-8 31713447-9 2019 Further results demonstrated that CK2alpha could interact with YBX1 and PI3K/AKT antagonist decreased cell resistance to doxorubicin induced by co-activation of CK2alpha and YBX1. Doxorubicin 121-132 casein kinase 2 alpha 2 Homo sapiens 34-42 31713447-9 2019 Further results demonstrated that CK2alpha could interact with YBX1 and PI3K/AKT antagonist decreased cell resistance to doxorubicin induced by co-activation of CK2alpha and YBX1. Doxorubicin 121-132 casein kinase 2 alpha 2 Homo sapiens 161-169 26172393-4 2015 Furthermore, CK2alpha and CK2alpha", catalytic subunits of CK2, were observed to translocate into nuclear in cancer cells with the treatment of DOX. Doxorubicin 144-147 casein kinase 2 alpha 2 Homo sapiens 13-21 26172393-4 2015 Furthermore, CK2alpha and CK2alpha", catalytic subunits of CK2, were observed to translocate into nuclear in cancer cells with the treatment of DOX. Doxorubicin 144-147 casein kinase 2 alpha 2 Homo sapiens 26-34 22695718-3 2012 Knockdown of CK2alpha in MCF7-derived cells expressing MRP1 [MRP1 CK2alpha(-)] resulted in increased doxorubicin sensitivity. Doxorubicin 101-112 casein kinase 2 alpha 2 Homo sapiens 13-21 22695718-3 2012 Knockdown of CK2alpha in MCF7-derived cells expressing MRP1 [MRP1 CK2alpha(-)] resulted in increased doxorubicin sensitivity. Doxorubicin 101-112 casein kinase 2 alpha 2 Homo sapiens 66-74 22695718-6 2012 Studies in tissue culture confirmed these findings, showing increased intracellular doxorubicin accumulation in MRP1 CK2alpha(-) and MRP1-T249A cells compared with MRP1 cells. Doxorubicin 84-95 casein kinase 2 alpha 2 Homo sapiens 117-125